Matthew Wikler
Director/Board Member at MATINAS BIOPHARMA HOLDINGS, INC.
Net worth: 52 866 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jerome Jabbour | M | 50 | 11 years | |
| Herbert Conrad | M | 91 | 11 years | |
| Eric Ende | M | 55 | 7 years | |
| Natasha Giordano | F | 62 | 4 years | |
| James Scibetta | M | 59 | 11 years | |
| Kathryn Corzo | F | 63 | 3 years | |
| Theresa Matkovits | M | 56 | 6 years | |
| Thomas Hoover | M | 55 | 3 years | |
| James Ferguson | M | 70 | 5 years | |
| Keith Kucinski | M | 55 | 5 years | |
| Hui Liu | M | 56 | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 years | |
| Lamberto Andreotti | M | 73 | 19 years | |
| Paul Truex | M | 55 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 4 years |
| Roelof Rongen | M | 59 | 5 years | |
| Dennis Podlesak | M | 66 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 2 years |
| Gregory C. Williams | M | 65 | 7 years | |
| Fouad Namouni | M | 55 | 21 years | |
| Dana Krzyston | F | - |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | - |
| Lewis B. Campbell | M | 77 | 18 years | |
| Leif Valdemar Johansson | M | 73 | 13 years | |
| Pat LePore | M | 69 | 3 years | |
| Joseph Squicciarino | M | 67 | 22 years | |
| Stefano Ferrari | M | 55 | 5 years | |
| Gerald Bruce | M | 68 | 8 years | |
| Brian Daniels | M | 65 | 14 years | |
| John E. Elicker | M | 64 | 20 years | |
| Gary Gaglione | M | 72 | 5 years | |
| Laurie Glimcher | M | 72 | 20 years | |
| Dirk Thye | M | 54 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 4 years |
| Dominick DiPaolo | M | 49 | 1 years | |
| Paul Antinori | M | 70 | 12 years | |
| Barry J. Wolfenson | M | 57 | 23 years | |
| Charles Sigal | M | 72 | 16 years | |
| Jason Haddock | M | 54 | 14 years | |
| Rebecca Taub | M | 71 | 3 years | |
| Brian Crynes | M | 77 | 3 years | |
| Lie Ping Chen | M | - | - | |
| Georgia Keresty | M | 62 | 4 years | |
| Kenneth E. Lebioda | M | - | 5 years | |
| Robert Peach | M | 68 | 9 years | |
| Kevin McManus | M | - | 9 years | |
| David Cohen | M | - | 8 years | |
| Yadagiri R Pendri | M | 68 | 7 years | |
| Benjamin Winograd | M | 63 | 9 years | |
| Michael Tardugno | M | 73 | 2 years | |
| Adam Dubow | M | 57 | - | |
| Elliott Levy | M | 64 | 17 years | |
| Samuel Barker | M | 81 | - | |
| Mark Trudeau | M | 62 | 11 years | |
| Larry K. Benedict | M | 63 | 7 years | |
| Miguel Forte | M | 63 | 5 years | |
| Cheryl Capps | F | 62 | 13 years | |
| Fu-Min Su | M | - | 6 years | |
| Kimberly Gentile | F | 56 | 14 years | |
| Charles Conway | M | 62 | 17 years | |
| Ning Yan | M | - | 7 years | |
| Michael Giordano | M | 66 | 18 years | |
| Elizabeth Yamashita | F | - | 6 years | |
| Douglas Hay | M | - | 6 years | |
| Dieter Weinand | M | 63 | 9 years | |
| Laurie Alsup | M | 70 | 10 years | |
| Kenneth F. Anderson | M | - | 17 years | |
| Christopher Lowe | M | 56 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 1 years |
| James T. Crines | M | 64 | 2 years | |
| Daniel M. Bollag | M | 63 | 2 years | |
| Kevin Rooney | M | 58 | 6 years | |
| Timothy McNamara | M | 67 | 9 years | |
| Robert Francis Doman | M | 74 | 8 years | |
| David L. Zabor | M | 69 | - | |
| James G. Ham | M | 74 | 7 years | |
| Steven R. Arikian | M | 65 | 2 years | |
| Phillip John Brancazio | M | 71 | 23 years | |
| Dean Mitchell | M | 68 | 3 years | |
| Stephen E. Bear | M | 73 | 7 years | |
| Beth Seidenberg | M | 67 | 2 years | |
| Timothy P. Cost | M | 65 | 5 years | |
| Gregg L. Bienstock | M | 59 | 1 years | |
| Michael J. Howerton | M | 72 | - | |
| Richard J. White | M | 82 | 12 years | |
| Susan Mahony | M | 59 | 5 years | |
| Helen Torley | M | 61 | 5 years | |
| Joachim von Roy | M | 79 | - | |
| Andrew Bodnar | M | 75 | - | |
| Peter S. Linsley | M | 72 | 14 years | |
| Jane A. Kramer | F | 68 | 11 years | |
| Gary Dickinson | M | 72 | 4 years | |
| Peter Kiener | M | 72 | 18 years | |
| Rajesh K. Malik | M | 65 | 2 years | |
| Jonathan Mow | M | 59 | 2 years | |
| Paul S. Anderson | M | 85 | 1 years | |
| Stuart Tross | M | 57 | 8 years | |
| Mark E. McGovern | M | 70 | 11 years | |
| Robert L. Simon | M | 79 | 13 years | |
| Daniel Lynch | M | 65 | 15 years | |
| Louis T. DiFazio | M | 86 | 7 years | |
| Nicole Onetto | M | 71 | 6 years | |
| John D. Macomber | M | 96 | 5 years | |
| Stephen Sadove | M | 72 | 10 years | |
| debra j bass | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Matthew Wikler
- Personal Network
